Opportunity Information: Apply for SM 13 013
Apply for SM 13 013
- The Substance Abuse Mental Health Services Adminis. in the health sector is offering a public funding opportunity titled "FY 2013 Program Supplement for MAI TCE Program Enhancement of HIV Care and Outcomes through Screening for Substance Use and Mental Disorders" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.243 Substance Abuse and Mental Health ServicesProjects of Regional and National Significance.
- This funding opportunity was created on Aug 2, 2013 and posted on Jul 17, 2013.
- Applicants must submit their applications by Aug 23, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $750,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- The number of recipients for this funding is limited to 3 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- The purpose of this program supplement is to screen persons who are presenting for or receiving HIV care in specialized HIV treatment services programs for substance use and mental disorders and make appropriate referrals, as necessary, to behavioral health treatment and/or prevention services. All individuals screened will be provided with education to prevent substance use and mental disorders among those who are HIV positive, information on how persons living with HIV might mitigate their risk of substance use and mental disorders, and information on what to do if behavioral health issues arise. In addition, because substance use and mental disorders can contribute to HIV infected individuals having difficulty adhering to HIV treatment, this program will improve HIV outcomes, which may reduce risk of transmitting the virus. The MAI TCE program targets comprehensive service approaches in the 11 Metropolitan Statistical Areas (MSAs) and Metropolitan Divisions (MDs) most impacted by HIV/AIDS. MAI TCE grantees funded under RFA #SM 11 006 are currently providing screening and referral to treatment for those who require care or preventive interventions for HIV and substance use and mental disorders. These grantees include Texas State Dept. of Health Services Florida State Dept. of Health Puerto Rico Dept. of Health City of Philadelphia Public Health Dept. San Francisco Dept. of Public Health New York City Health/Mental Hygiene Chicago Dept. of Public Health Los Angeles County Office of AIDS Programs Policies Maryland State Dept. of Health/Mental Hygiene D.C. Dept. of Health and Georgia State Dept. of Public Health.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The FY 2013 Program Supplement for the MAI TCE Program, titled "Enhancement of HIV Care and Outcomes through Screening for Substance Use and Mental Disorders" (Funding Opportunity Number SM 13 013), is a SAMHSA supplemental cooperative agreement designed to expand and strengthen work already underway through the Minority AIDS Initiative Targeted Capacity Expansion (MAI TCE) Integrated Behavioral Health/Primary Care Network awards originally funded under RFA SM 11 006. The supplement reflects SAMHSA's push to deepen integration between HIV clinical care and behavioral health by moving beyond general network development and placing screening and referral activities directly into specialized HIV treatment service settings, particularly in communities of color that are disproportionately affected by HIV/AIDS.
At the program level, the supplement builds on the MAI TCE program's original goal of developing culturally competent, effective integrated behavioral health and primary care networks that include HIV services and medical treatment. The core geographic focus remains the 11 Metropolitan Statistical Areas and Metropolitan Divisions most impacted by HIV/AIDS, where MAI TCE grantees are already operating. What changes with this supplement is the emphasis: funds are specifically intended to expand behavioral health services into specialized HIV treatment programs so that screening for substance use disorders and mental disorders becomes a routine, embedded component of HIV care rather than a separate or loosely connected service.
The main purpose of the supplement is straightforward but clinically significant: when people present for HIV care, or are already receiving HIV care in specialized HIV treatment settings, grantees are expected to screen them for substance use and mental disorders and then connect them to appropriate behavioral health treatment and/or prevention services when needs are identified. The opportunity also requires that every individual who is screened receive education aimed at preventing substance use and mental disorders among people living with HIV. This education component includes practical information on how HIV-positive individuals can reduce or mitigate their risk for developing or worsening substance use or mental health conditions, as well as guidance on what steps to take if behavioral health concerns arise. In other words, the supplement is not limited to identifying problems; it also supports prevention-oriented messaging and early intervention that can be delivered broadly across the HIV care population.
A central rationale for this approach is the well-established link between untreated substance use or mental health conditions and poorer HIV outcomes, particularly challenges with adherence to HIV treatment. By identifying and addressing behavioral health needs earlier and more consistently within HIV care environments, the supplement is designed to improve HIV-related health outcomes. Better adherence and stability can also have a public health impact by reducing the likelihood of HIV transmission, since effective HIV treatment that is taken as prescribed can lower viral load and, as a result, transmission risk.
SAMHSA signals an expectation that funded activities rely on evidence-based practices, directing applicants to SAMHSA's Guide to Evidence-Based Practices (www.samhsa.gov/ebpwebguide). This requirement underscores that screening tools, referral workflows, and prevention or treatment interventions should be grounded in established research and proven models rather than ad hoc approaches. The supplement is jointly supported across SAMHSA's Centers for Substance Abuse Prevention, Substance Abuse Treatment, and Mental Health Services, highlighting that the initiative is intended to address the full continuum from prevention to treatment across both substance use and mental health.
From an administrative and funding standpoint, this is a discretionary opportunity using a cooperative agreement mechanism, which typically means SAMHSA anticipates substantial involvement and collaboration with awardees during implementation. The estimated total funding available was $750,000, with an anticipated three awards and an award ceiling of $250,000 per award. There was no cost sharing or matching requirement. The opportunity was posted July 17, 2013, with an original closing date of August 16, 2013, later extended to August 23, 2013, and it was archived September 22, 2013. The CFDA number listed is 93.243, under Substance Abuse and Mental Health Services Projects of Regional and National Significance.
Eligibility is effectively limited to existing MAI TCE grantees funded under RFA SM 11 006, since this is a supplement meant to expand or enhance those active projects rather than fund entirely new entrants. The announcement explicitly identifies the MAI TCE grantees, including state and local public health departments and related agencies such as the Texas State Department of Health Services, Florida State Department of Health, Puerto Rico Department of Health, City of Philadelphia Public Health Department, San Francisco Department of Public Health, New York City Department of Health and Mental Hygiene, Chicago Department of Public Health, Los Angeles County Office of AIDS Programs and Policies, Maryland State Department of Health and Mental Hygiene, the D.C. Department of Health, and the Georgia State Department of Public Health. These entities were already conducting screening and referral activities related to HIV, substance use, and mental disorders, and this supplement is meant to push those capabilities further into specialized HIV treatment service programs.
For applicants needing assistance with the announcement, SAMHSA provided a grants management contact: Gwendolyn Simpson, Office of Financial Resources, Division of Grants Management, Substance Abuse and Mental Health Services Administration, 1 Choke Cherry Road, Room 7-1091, Rockville, MD 20857, phone (240) 276-1408, email gwendolyn.simpson@samhsa.hhs.gov.
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This is the FY 2013 Program Supplement for the MAI TCE Program titled "Enhancement of HIV Care and Outcomes through Screening for Substance Use and Mental Disorders" (Funding Opportunity Number SM 13 013). It is a SAMHSA supplemental cooperative agreement intended to expand and strengthen work already underway through the Minority AIDS Initiative Targeted Capacity Expansion (MAI TCE) Integrated Behavioral Health/Primary Care Network awards originally funded under RFA SM 11 006.
What is the main goal of the supplement?
The supplement is designed to deepen integration between HIV clinical care and behavioral health by embedding screening and referral activities directly into specialized HIV treatment service settings. The aim is for screening for substance use disorders and mental disorders to become a routine part of HIV care, with follow-up connection to appropriate behavioral health treatment and/or prevention services when needs are identified.
How does this supplement differ from the original MAI TCE network focus?
While the original MAI TCE effort focused on developing integrated behavioral health and primary care networks (including HIV services and medical treatment), this supplement shifts emphasis toward implementation inside specialized HIV treatment programs. It moves beyond general network development by placing screening, education, and referral workflows directly into HIV treatment service settings.
What populations and communities are emphasized?
The supplement highlights specialized HIV treatment settings, particularly in communities of color that are disproportionately affected by HIV/AIDS. The broader MAI TCE geographic focus remains the 11 Metropolitan Statistical Areas and Metropolitan Divisions most impacted by HIV/AIDS where MAI TCE grantees are already operating.
What activities are grantees expected to carry out?
Within specialized HIV treatment settings, grantees are expected to:
- Screen individuals who present for HIV care, or who are already receiving HIV care, for substance use disorders and mental disorders.
- Connect individuals to appropriate behavioral health treatment and/or prevention services when screening identifies needs.
- Provide education to every individual who is screened, focused on preventing substance use and mental disorders among people living with HIV.
Is education required even if the screening does not identify a problem?
Yes. The opportunity specifies that every individual who is screened must receive education aimed at preventing substance use and mental disorders among people living with HIV. The education is intended to provide practical prevention-oriented information and guidance on steps to take if behavioral health concerns arise.
Why is SAMHSA focusing on substance use and mental disorder screening in HIV care settings?
The rationale described in the announcement is that untreated substance use or mental health conditions are strongly linked to poorer HIV outcomes, including challenges with adherence to HIV treatment. Earlier and more consistent identification and linkage to behavioral health services within HIV care environments is intended to improve HIV-related health outcomes. Improved adherence and stability may also reduce HIV transmission risk by helping individuals maintain effective HIV treatment and lower viral load.
Does SAMHSA require evidence-based practices?
Yes. SAMHSA indicates an expectation that funded activities rely on evidence-based practices and directs applicants to SAMHSA's Guide to Evidence-Based Practices (www.samhsa.gov/ebpwebguide). This means screening tools, referral workflows, and prevention or treatment interventions are expected to be grounded in established research and proven models.
Which SAMHSA centers support this supplement?
The supplement is jointly supported across SAMHSA's Center for Substance Abuse Prevention, Center for Substance Abuse Treatment, and Center for Mental Health Services. This reflects an intent to address prevention and treatment across both substance use and mental health needs.
What type of award mechanism is used?
This is a discretionary funding opportunity using a cooperative agreement mechanism. A cooperative agreement typically means SAMHSA anticipates substantial involvement and collaboration with awardees during implementation.
How much funding was available and how many awards were anticipated?
The estimated total funding available was $750,000, with an anticipated three awards. The award ceiling was $250,000 per award.
Is cost sharing or matching required?
No. The announcement states there was no cost sharing or matching requirement.
Who was eligible to apply?
Eligibility was effectively limited to existing MAI TCE grantees funded under RFA SM 11 006 because this is a supplement intended to expand or enhance those active projects rather than fund entirely new entrants.
Which entities were identified as MAI TCE grantees for this supplement?
The announcement identifies MAI TCE grantees including:
- Texas State Department of Health Services
- Florida State Department of Health
- Puerto Rico Department of Health
- City of Philadelphia Public Health Department
- San Francisco Department of Public Health
- New York City Department of Health and Mental Hygiene
- Chicago Department of Public Health
- Los Angeles County Office of AIDS Programs and Policies
- Maryland State Department of Health and Mental Hygiene
- D.C. Department of Health
- Georgia State Department of Public Health
What is the CFDA number for this opportunity?
The CFDA number listed is 93.243, under Substance Abuse and Mental Health Services Projects of Regional and National Significance.
What were the key dates for this opportunity?
- Posted: July 17, 2013
- Original closing date: August 16, 2013
- Extended closing date: August 23, 2013
- Archived: September 22, 2013
Where are funded activities intended to take place?
Activities are intended to be implemented within specialized HIV treatment service settings in the geographic areas where the MAI TCE grantees were already operating, with the overall MAI TCE focus remaining on the 11 Metropolitan Statistical Areas and Metropolitan Divisions most impacted by HIV/AIDS.
What is the funding opportunity number?
The Funding Opportunity Number is SM 13 013.
Who can applicants contact for grants management questions?
SAMHSA listed the following grants management contact for assistance with the announcement:
Gwendolyn Simpson
Office of Financial Resources, Division of Grants Management
Substance Abuse and Mental Health Services Administration
1 Choke Cherry Road, Room 7-1091
Rockville, MD 20857
Phone: (240) 276-1408
Email: gwendolyn.simpson@samhsa.hhs.gov
Browse more opportunities from the same category: Health
Next opportunity: Elevation Mapping of Critical Park Areas for Planning and Post and Future Storm Evaluation and Modeling
Previous opportunity: High Priority Behavioral and Social Research Networks (R24)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for SM 13 013
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (SM 13 013) also looked into and applied for these:
| Funding Opportunity |
|---|
| Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage II (CADET II)(UH2/UH3) Apply for RFA HL 14 001 Funding Number: RFA HL 14 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Empowering Communities for Health (ECH) Project Apply for RFA 442 13 000004 Funding Number: RFA 442 13 000004 Agency: Cambodia USAID Phnom Penh Category: Health Funding Amount: $15,000,000 |
| NIDCD National Temporal Bone, Hearing Balance Pathology Resource Registry (U24) Apply for RFA DC 14 002 Funding Number: RFA DC 14 002 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Adding Legacy Clinical Data to the Federal Interagency Traumatic Brain Injury (FITBIR) Informatics System (R03) Apply for RFA NS 14 002 Funding Number: RFA NS 14 002 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Collaborative Research Infrastructure to Develop Research Strategies to Identify Potential Therapeutic Targets Based on Genetic Factors Influencing Human Life Span and Health Span (U24) Apply for RFA AG 14 003 Funding Number: RFA AG 14 003 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| American Indians into Nursing Apply for HHS 2013 IHS NU 0001 Funding Number: HHS 2013 IHS NU 0001 Agency: Indian Health Service Category: Health Funding Amount: $350,000 |
| NIDCD Clinical Research Center Grant (P50) Apply for PAR 13 277 Funding Number: PAR 13 277 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| USAID/Uganda Advocacy for Better Better Health Apply for RFA 617 13 000006 Funding Number: RFA 617 13 000006 Agency: Uganda USAID Kampala Category: Health Funding Amount: $20,000,000 |
| Limited Competition NIMHD Research Centers in Minority Institutions Infrastructure for Clinical and Translational Research (RCTR) U54 Apply for PAR 13 279 Funding Number: PAR 13 279 Agency: National Institutes of Health Category: Health Funding Amount: $3,100,000 |
| Clinical Trials in Organ Transplantation (CTOT) (U01) Apply for RFA AI 13 006 Funding Number: RFA AI 13 006 Agency: National Institutes of Health Category: Health Funding Amount: $1,750,000 |
| Support of NIGMS Program Project Grants (P01) Apply for PAR 13 280 Funding Number: PAR 13 280 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMHD Social, Behavioral, Health Services, and Policy Research on Minority Health and Health Disparities (R01) Apply for RFA MD 13 006 Funding Number: RFA MD 13 006 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| NINDS Phase III Investigator Initiated Efficacy Clinical Trials (U01) Apply for PAR 13 278 Funding Number: PAR 13 278 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Money Follows the Person Rebalancing Demonstration Grant Tribal Initiative Apply for CMS 1LI 14 001 Funding Number: CMS 1LI 14 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $1,000,000 |
| NINDS Exploratory Clinical Trials (R01) Apply for PAR 13 281 Funding Number: PAR 13 281 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Audacious Goals Initiative in Vision Research High Priority Research Area Molecular Therapies for Eye Disease (R01) Apply for PA 13 283 Funding Number: PA 13 283 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing Newborn, Child and Reproductive Health (ANCRE) Apply for USAID BENIN 680 13 00000 RFA Funding Number: USAID BENIN 680 13 00000 RFA Agency: Benin USAID Cotonou Category: Health Funding Amount: $10,000,000 |
| NIMHD Basic and Applied Biomedical Research on Minority Health and Health Disparities (R01) Apply for RFA MD 13 008 Funding Number: RFA MD 13 008 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Veterans to Nurses and Physician Assistants Workforce Program Apply for HRSA 13 275 Funding Number: HRSA 13 275 Agency: Health Resources and Services Administration Category: Health Funding Amount: $370,000 |
| IHS National HIV Program Apply for HHS 2013 IHS OCPS HIV 0001 Funding Number: HHS 2013 IHS OCPS HIV 0001 Agency: Indian Health Service Category: Health Funding Amount: $90,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "SM 13 013", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.